Drugs / GRT6010
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01485094 | Feb 2012 → Jan 2013 | neuralgia | Grünenthal GmbH | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GRT6010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01485094 ↗ |
| Modality | Small molecule | — CHEMBL6068550 ↗ |
| Route | Oral | “Oral solution given once daily.” NCT01485094 ↗ |